QQ客服 官方微博 反馈留言

	Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial
	Jin, Jie; Wang, Jian-Xiang; Chen, Fei-Fei; Wu, De-Pei; Hu, Jiong; Zhou, Jian-Feng; Hu, Jian-Da; Wang, Jian-Min; Li, Jian-Yong; Huang, Xiao-Jun
刊名	LANCET ONCOLOGY
	2013
卷号	14期号:7
ISSN号	1470-2045
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4903133
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Jin, Jie,Wang, Jian-Xiang,Chen, Fei-Fei,et al. Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial[J]. LANCET ONCOLOGY,2013,14(7).
APA	Jin, Jie.,Wang, Jian-Xiang.,Chen, Fei-Fei.,Wu, De-Pei.,Hu, Jiong.,...&Chen, Sai-Juan.(2013).Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.LANCET ONCOLOGY,14(7).
MLA	Jin, Jie,et al."Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial".LANCET ONCOLOGY 14.7(2013).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。